Privacy & Cookies Policy
This website uses cookies to improve your experience. We'll assume
you're ok with this, but you can opt-out if you wish.Cookie settings
The ASSURE Study: HIV-1 Suppression Is Maintained with Bone and Renal Biomarker Improvement 48 Weeks after Ritonavir Discontinuation and Randomized Switch to Abacavir/Lamivudine + Atazanavir. HIV Medicine, 17(2): 106-117.
Author:
Bhatti L, DeJesus E, Edelstein H, Margolis DA, Ross LL, Shaefer MS, Small CB, Weinberg WG, Wohl DA, Zhao HH
Cookies Popup
This website uses cookies to improve your experience. We’ll assume you’re ok with this, but you can opt-out if you wish. [cookie_settings] [cookie_button]